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Abstract  26 
Classification of body cavity effusions is an important step in the investigation and diagnosis 27 
of disease in cats. Feline inflammatory effusions are often highly proteinaceous and viscous, 28 
which can cause clumping of white cells and subsequently inaccurate nucleated cell counts 29 
using automated and manual methods. Microscopic assessment of cellularity can also be 30 
difficult due to the varying thickness of smears and cell clumping which skews white cell 31 
distribution.  The Advia 120 uses 2 white cell counting channels, the basophil/lobularity and 32 
differential/peroxidase channels which can provide quite different results in highly viscous 33 
feline samples and often disagree with smear assessment of cellularity. We investigated the 34 
effects of pre-incubation of feline effusion samples with hyaluronidase and its effects on 35 
nucleated cell counts and cellularity assessment. Nucleated cell counts were obtained by both 36 
automated analysis using the Advia 120 and manual counting methods. Agreement was 37 
assessed using a Bland-Altman chart. Pre-treatment of samples with hyaluronidase resulted in 38 
good agreement between the Advia basophil channel and manual counting methods in all 39 
samples in the study. However, improvements in nucleated cell counts after hyaluronidase 40 
treatment were significantly greater in clumped samples and cell distribution of these samples 41 
on direct smears was also improved. Therefore, when nucleated cell clumping is observed on 42 
a direct smear, pre-treatment of the sample with hyaluronidase prior to analysis on an 43 
automated analyzer is advised with the WBC/baso channel the most accurate nucleated cell 44 
counting channel. 45 
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Classification of body cavity effusions is an important step in the investigation and 52 
diagnosis of disease as it can give an indication of the underlying mechanism causing the 53 
abnormal fluid accumulation.8 Classification is achieved by measuring the protein 54 
concentration and the nucleated cell count (NCC) of the effusion. Nucleated cell counts are 55 
normally measured by using an automated hematology analyzer or manually by 56 
hemocytometer. However obtaining accurate NCCs from feline effusions is often problematic 57 
due to their high viscosity and the tendency for white cell clumping, and previous studies 58 
have indicated only moderate correlation between automated and manual methods when 59 
analysing fluid samples from this species.6  60 
Manual cell counting using a hemocytometer is the traditional method for obtaining 61 
fluid NCC. However this method is time consuming and possesses inherent error.11 Clumping 62 
of cells can also contribute to inaccurate cell counts using this method.7 Automated 63 
hematology analyzers in contrast provide rapid results that are less labor intensive to obtain 64 
compared to traditional cell counting methods. These analyzers also provide more accurate 65 
NCCs however  provided no nucleated cell clumping is present.11 The Advia 120a hematology 66 
analyzer measures white cells by 2 methods: the basophil/lobularity (WBC/baso) and the 67 
differential/peroxidase (WBC/perox) channel. The WBC/baso channel provides a total NCC; 68 
the WBC/perox channel provides both a differential NCC and a total NCC. Large 69 
discrepancies are often found between these 2 Advia 120 channels when analyzing feline 70 
effusions and this has also been reported when analysing feline effusions using the Sysmex 71 
XT-2000i.5 In our experience, examination of a direct smear of an effusion can indicate that 72 
neither NCC is accurate however microscopic assessment of the NCC from the direct smear 73 
is complicated by the thick nature of these smears and cell clumping, which skews the white 74 
cell distribution. 75 
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Problems with obtaining accurate NCCs have been encountered with other fluids that 76 
are of high viscosity. In synovial fluids, this has been overcome by pre-incubation of samples 77 
with hyaluronidase prior to analysis by automated analyzers.3,9 This technique has also been 78 
demonstrated to have utility in forensic medicine when analysing vitreous humor.4 The 79 
viscous nature of synovial fluid is caused by high levels of hyaluronic acid.10 Incubation with 80 
hyaluronidase causes the hydrolysis of hyaluronan and this decreases the viscosity of the 81 
sample. Hyaluronic acid has been shown to be increased in induced cases of peritonitis in 82 
rabbits2 and it is possible that this mechanism may contribute to the high viscosity of feline 83 
inflammatory body cavity effusions. We therefore hypothesized that pre-incubation of feline 84 
body cavity effusions with bovine testicular hyaluronidase will decrease the viscosity of the 85 
samples allowing more accurate NCC results by automated hematology analyzers and better 86 
distribution of cells on direct smears making assessment of cellularity easier. 87 
To test this hypothesis, feline body cavity effusions submitted to the clinical 88 
pathology laboratory of the University of Glasgow were analyzed both with and without pre-89 
incubation with hyaluronidase. The effusions were submitted to the laboratory in EDTA tubes 90 
and were analyzed on the day of arrival. Direct smears of the untreated samples were made 91 
and stained using the May-Grünwald Giemsa method. These smears were examined to 92 
determine cell distribution and the presence or absence of cell clumping. 93 
Automated NCCs were then obtained using the Advia120 and manual NCCs obtained 94 
by using a Neubauer counting chamber. To perform the manual NCC, 20µL of sample was 95 
added to 380 µL of 1% acetic acid in order to lyse erythrocytes (methyl violet was added to 96 
stain the nuclei). The sample was rotated gently for 2-3 min and then transferred to the 97 
Neubauer counting chamber using a capillary tube. The counting chamber was left in a moist 98 
chamber for 10 min to let cells settle before cell counting using a light microscope.1  99 
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After initial analysis of the untreated sample, a 250 µL aliquot of sample was added to 100 
250 µL of hyaluronidase (150 U/mL) and incubated at 37 °C for 10 min.  The hyaluronidase 101 
solution of 150 U/mL had been prepared by dissolving 10 mg of bovine testicular 102 
hyaluronidaseb solution (439 units/mg) in 30 mL of saline buffer (0.9 g/L).  After 10min of 103 
incubation with hyaluronidase, the treated sample was run through the automated hematology 104 
analyzer (Advia 120) to obtain automated NCCs. Manual NCCs on the treated sample were 105 
performed as described above. Results obtained were then corrected for the dilution caused 106 
by hyaluronidase added to the sample. A direct smear was also made immediately after 107 
incubation to assess white blood cell distribution and presence of clumping. Samples were 108 
thoroughly mixed in all instances before performing any procedures. 109 
To demonstrate the action of hyaluronidase and confirm that any changes in the results 110 
obtained were not caused solely to dilution, an equal amount of normal saline was added to 111 
an aliquot of untreated sample. The mixture was incubated at 37°C for 10 min and NCCs 112 
obtained using the Advia120 and manually with the hemocytometer.   113 
Fluid protein measurements on untreated samples were obtained using the Biuret 114 
method on a Olympus AU640 analyzerc.  115 
Results from the Advia 120 and manual counts were compared using Pearson’s 116 
correlation (r) and Bland-Altman plots. Fluid protein levels in clumped and non-clumped 117 
samples were compared using Student’s t-test. The manual NCC obtained from hyaluronidase 118 
treated samples was considered the benchmark result as the presence or absence of clumping 119 
could be ascertained at the time of analysis. Statistical significance was established at 120 
(p<0.05). Data were analyzed using a spreadsheet software packaged. 121 
Repeatability of NCC from the Advia120 in untreated samples was assessed on 2 122 
samples with no obvious nucleated cell clumping and 1 sample with clumping observed by 123 
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collecting 5 consecutive measurements of each on the same day and then calculating the 124 
coefficient of variation (CV) with the formula CV = standard deviation (SD)/mean x100. 125 
Precision of the analyzer was found to be adequate when analyzing non-clumping 126 
samples, with WBC/baso channel CVs <5%. However the CVs from the sample where 127 
clumping was present were much greater (see Table 1). 128 
In total, 25 feline body cavity effusions were submitted to the diagnostic service 129 
during the time of the study (13 peritoneal, 12 pleural), and counts were obtained as noted 130 
above (Table 2).  131 
Smears made from untreated samples were assessed for white cell clumping and this 132 
phenomenon was noted in 13/25 samples (9 peritoneal, 4 pleural,Table 2).  Smears prepared 133 
from hyaluronidase-treated samples showed improved white cell distribution with no cell 134 
clumping. This allowed easier assessment of cellularity (taking into account the dilution 135 
factor) by microscopy.  136 
Nucleated cell counts from untreated samples obtained from both the WBC/baso 137 
channel and WBC/perox channel showed moderate correlation with NCCs obtained from 138 
treated samples counted by the manual method (r = 0.68 and r = 0.84 respectively). These 139 
results are similar to a previous study of body cavity effusions from different animal species, 140 
which found only moderate correlation (r = 0.73) between cells counts obtained from the 141 
Advia 120 WBC/baso channel and the standard hemocytometer method in feline peritoneal 142 
effusions.6 The Bland-Altman agreement charts showed that both the WBC/baso and 143 
WBC/diff channels underestimated the NCCs and this error was greater in samples where cell 144 
clumping was observed. Furthermore, the presence of cell clumping was more common in 145 
samples with higher cell counts (Fig. 1A and 1B).  146 
After hyaluronidase treatment, greater agreement between the WBC/baso channel and 147 
the standard hemocytometer method was shown in both clumping and non-clumping samples 148 
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treated with hyaluronidase (Fig. 1C), however the magnitude of improvement was 149 
significantly greater in the clumped samples (Student’s t-test, p<0.01). The most reliable 150 
NCC obtained from the automated analyzer in the treated samples was obtained from the 151 
WBC/baso channel as results showed good correlation with the manual cells counts 152 
(Pearson’s correlation coefficient of r = 0.99). As greater agreement was seen in both 153 
clumping and non-clumping samples, it could be argued that treating all feline effusions with 154 
hyaluronidase prior to analysis would be beneficial. However, as the cellularity of samples 155 
with no clumping tended to be low and the increase in NCC post-treatment small, 156 
hyaluronidase incubation of samples with no clumping is unlikely to lead to significant 157 
changes in the classification or interpretation of results. Clumped samples had statistically 158 
significant greater fluid protein levels than non-clumped samples (Student’s t-test, p=0.024) 159 
however fluid protein was not predictive of the need for enzyme treatment as there was a 160 
large overlap between the groups; many non-clumped samples had high fluid protein (Table 161 
2). Enzymatic treatment should therefore be limited to samples where clumping is noted on 162 
examination of a direct smear of the effusion.  163 
In contrast to the WBC/baso channel, the NCCs from the WBC/perox channel 164 
decreased after treatment and this resulted in the WBC/perox channel counts being markedly 165 
low post-treatment when compared to results from the WBC/baso channel, the manual cell 166 
count and visual assessment on a direct smear (see Table 2). The reason for the decrease in 167 
the WBC/perox channel NCCs post-treatment is unclear particularly as smear assessment 168 
demonstrated that white cell clumping in the samples had resolved after treatment with 169 
hyaluronidase. Analysis of the WBC/perox scatter plot shows more events in the “noise” 170 
region in treated samples and we hypothesize that enzyme treatment causes increased 171 
fragility of the cells which then disintegrate in WBC/perox channel. 172 
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The results of this study are in contrast to the recommendations by Giordano et al.5 173 
who demonstrated high diagnostic accuracy of the TNC (the ratio of the WBC/perox and 174 
WBC/baso counts) for diagnosis of FIP in feline effusions. This disparity in NCC between 175 
the WBC/perox and WBC /baso channels, they hypothesize, is due to the acidic WBC/baso 176 
reagent causing precipitation of proteins with subsequent entrapment of nucleated cells and 177 
low NCCs. Consequently, they advise use of the WBC/perox channel for nucleated cell 178 
counts in feline effusions. However, the samples in their study were not pre-treated with 179 
hyaluronidase. We demonstrate in Fig. 1B, that while the WBC/perox NCC is likely to be 180 
more accurate in untreated samples, if cell clumping is present the NCC values are likely to 181 
be underestimated by automated analyzers. 182 
Dilution of the samples with an equal volume of saline did not improve the accuracy 183 
of the analyzer cell counts (data not shown). This along with the success of the hyaluronidase 184 
would support the hypothesis that substances such as hyaluronan contribute to the highly 185 
viscous nature of some of these effusions. 186 
In summary, pre-treatment with hyaluronidase improved the NCCs obtained from the 187 
WBC/baso channel in all samples in the study. Greatest improvement was seen in samples 188 
where nucleated cell clumping was observed on a direct smear whereas samples with no 189 
clumping observed had only small improvements in NCC. Fluid protein was significantly 190 
higher in clumped samples but was not a good predictor for the requirement of enzyme 191 
treatment therefore the decision for enzyme treatment should be based on the presence of 192 
nucleated cell clumping.  The WBC/diff channel NCCs  were consistently decreased by 193 
treatment and therefore this channel was not reliable for determining accurate NCC after 194 
enzyme treatment. Finally, pre-treatment with hyaluronidase produced more even distribution 195 
of white cells on a direct smear allowing easier assessment of cellularity by microscopy.   196 
197 
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Tables 249 
Table 1. Precision data for nucleated cell counts from untreated feline effusions using 250 
both Advia 120 WBC/baso and WBC/perox channels. 251 
Sample Advia 
channel 
Mean 
(NCCx109/L) 
SD CV (%) 
1* WBC/baso 1.74 0.38 21.8 
WBC/perox 0.92 0.32 34.8 
2 WBC/baso 2.24 0.07 3.12 
WBC/perox 1.23 0.24 19.5 
3 WBC/baso 4.64 0.12 2.58 
WBC/perox 2.43 0.58 23.9 
* = nucleated cell clumping present on the direct smear.252 
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Table 2. Total nucleated cell counts and fluid protein measurements. 253 
Sample 
no./site 
 Advia 
WBC/baso 
channel 
(x 109/L) 
Advia 
WBC/Perox 
Channel 
(x 109/L) 
Manual cell 
count 
(x 109/L) 
Fluid 
Protein 
g/dL 
1* Untreated 10.57 10.57   
Peritoneal Hya treated 15.10 5.70 13.4 6.6 
2 Untreated 42.44 37.10   
Pleural Hya treated 48.74 18.48 43 3.0 
3 
Peritoneal 
Untreated 2.49 3.10   
Hya treated 3.92 1.82 5.2 4.9 
4* 
Pleural 
Untreated 4.78 7.63   
Hya treated 10.60 6.40 10.9 4.1 
5* 
Peritoneal 
Untreated 2.28 3.01   
Hya treated 4.4 0.64 5.4 4.7 
6* 
Peritoneal 
Untreated 9.25 1.67   
Hya treated 11.06 0.56 11.8 3.2 
7* 
Peritoneal 
Untreated 1.14 2.22   
Hya treated 3.98 1.72 4 7.0 
8 
Pleural 
Untreated 1.21 0.43   
Hya treated 1.50 0.52 1.9 3.7 
9* 
Peritoneal 
Untreated 1.87 3.24   
Hya treated 9.66 2.28 9.8 8.5 
10 
Pleural 
Untreated 13.50 9.77   
Hya treated 12.60 5.22 14 5.2 
11 
Pleural 
Untreated 1.69 3.64   
Hya treated 3.62 1.52 4.2 6.1 
12 
Peritoneal 
Untreated 4.59 3.37   
Hya treated 4.84 2.8 4.6 4.4 
13 
Peritoneal 
Untreated 1.65 1.04   
Hya treated 1.88 1.00 2.4 4.1 
14* 
Pleural 
Untreated 88.85 88.85   
Hya treated 241.36 32.88 202 5.7 
15 
Pleural 
Untreated 0.37 1.50   
Hya treated 1.14 1.14 1.7 5.0 
16 
Peritoneal 
Untreated 0.32 0.72   
Hya treated 1.46 0.76 1.3 4.1 
17 
Pleural 
Untreated 4.68 4.68   
Hya treated 5.58 4.08 5.9 6.2 
18 
Pleural 
Untreated 0.76 0.39   
Hya treated 0.98 0.36 0.8 2.4 
19 
Pleural 
Untreated 0.10 0.06   
Hya treated 0.10 0.04 0.1 0.2 
20* 
Pleural 
Untreated 3.17 8.67   
Hya treated 17.72 6.42 17.7 7.5 
21* 
Peritoneal 
Untreated 2.71 2.36   
Hya treated 4.60 1.94 4.95 6.0 
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22* 
Peritoneal 
Untreated 1.48 7.03   
Hya treated 9.28 3.18 8.6 4.1 
23* 
Peritoneal 
Untreated 0.65 2.17   
Hya treated 3.52 1.72 3.7 ND 
24* 
Pleural 
Untreated 0.83 4.2   
Hya treated 6.36 1.14 6.6 4.9 
25* 
Peritoneal 
Untreated 1.91 3.59   
Hya treated 9.56 2.62 8.7 5.6 
 254 
Total nucleated cell counts obtained from automated analyser channels WBC/baso and 255 
WBC/perox for both untreated and hyaluronidase treated samples and manual method using 256 
hyaluronidase treated samples with corresponding fluid protein measurements. * = white cell 257 
clumping observed on direct smears of untreated sample. ND = no data.258 
 16 
Figure legends 259 
Figure 1A-C. Bland-Altman plots of NCCs obtained from feline body cavity effusions using 260 
the hemocytometer and the Advia 120 WBC/baso and WBC/perox channels. Agreement 261 
between the NCC obtained using hyaluronidase treated samples counted by the manual 262 
method (benchmark method) and untreated samples counted using the ADVIA 120 263 
WBC/baso (plot A) and WBC/diff (plot B) channels are shown. Positive values on the y-axis 264 
indicate a higher reading with the automated method while negative values indicate a higher 265 
reading with the manual counting method. Both automated channels underestimate the NCC 266 
in untreated samples.  Agreement between the NCCs of hyaluronidase treated samples using 267 
the Advia 120 WBC/baso and the manual method are shown in plot C. Good agreement is 268 
demonstrated between the manual method and the Advia 120 WBC/baso channel when 269 
counting treated samples. Two outliers with NCC >40x109/L were removed to improve 270 
graphical representation in the NCC range of interest.  271 
Dashed lines represent ±2SD, no tx = no hyaluronidase treatment, tx = hyaluronidase treated 272 
samples. 273 
 274 
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